Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Kyprolis clinical trials
11 selected ClinicalTrials.gov records carrying the official matched intervention Kyprolis (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
11 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 25 selected PubMed records and 6 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT01572480
PeptideScanner retained ClinicalTrials.gov record NCT01572480 at 2026-11-16T17:39:29.005Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was carfilzomib.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- March 10, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01813227
PeptideScanner retained ClinicalTrials.gov record NCT01813227 at 2026-11-16T17:39:29.005Z. Its registry update date was 2026-04-03, and PeptideScanner's reviewed identity mapping was carfilzomib.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- April 3, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01816971
PeptideScanner retained ClinicalTrials.gov record NCT01816971 at 2026-11-16T17:39:29.005Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was carfilzomib.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- April 21, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Carfilzomib · 2026-11-02
ClinicalTrials.gov record NCT05497804
Active, not recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-10-06
ClinicalTrials.gov record NCT04430894
Active, not recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-09-15
ClinicalTrials.gov record NCT04756401
Active, not recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-05-11
ClinicalTrials.gov record NCT03934684
Completed at the retained observation.
Open attributed record →Carfilzomib · 2026-04-21
ClinicalTrials.gov record NCT01816971
Completed at the retained observation.
Open attributed record →Carfilzomib · 2026-04-03
ClinicalTrials.gov record NCT01813227
Completed at the retained observation.
Open attributed record →Carfilzomib · 2026-03-20
ClinicalTrials.gov record NCT02773030
Active, not recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-03-10
ClinicalTrials.gov record NCT01572480
Completed at the retained observation.
Open attributed record →Carfilzomib · 2026-02-09
ClinicalTrials.gov record NCT03275285
Completed at the retained observation.
Open attributed record →Carfilzomib · 2025-09-04
ClinicalTrials.gov record NCT04191616
Completed at the retained observation.
Open attributed record →Carfilzomib · 2022-05-25
ClinicalTrials.gov record NCT03029234
Completed at the retained observation.
Open attributed record →